Dr Jay Ebert completed his PhD in cartilage repair, biomechanics and exercise rehabilitation at the University of Western Australia (UWA) in 2008, for which he was awarded the Exercise and Sports Science Australia (ESSA) Medal. Since this time, he has been involved academically at the School of Human Sciences within UWA, and is now a Lecturer and Researcher in musculoskeletal rehabilitation. Through his clinical and research work at UWA, he has been (and continues to be) involved in the project development and coordination of several large orthopaedic research programs, as well as student research supervision.

External to UWA, he is a Director of Research at the Perth Orthopaedic and Sports Medicine Research Institute, and a Director of the Orthopaedic Research Foundation of Western Australia. He is also a Director and Accredited Exercise Physiologist (AEP) at HFRC, a leading exercise rehabilitation clinic with a focus in muscluoskeletal and orthopaedic rehabilitation, located in Perth, Western Australia. He has practiced as an AEP since 2002, and was awarded the Exercise and Sport Science Australia (ESSA) ‘Exercise Physiologist of the Year’ in 2010. He has extensive experience working with patients of all musculoskeletal conditions, with a particular focus on lower limb injury and post-operative rehabilitation following orthopaedic surgery.

1. Ebert JR, Robertson WB, Ackland TR. (2006) Improving Patient Outcome Following Autologous Chondrocyte Implantation: Accelerated versus Conservative Rehabilitation. Hollywood Private Hospital Research Foundation, $8,424.
2. Wood DJ, Ebert JR. (2009) Prospective randomised clinical trial assessing the subsidence and rotation of the K2 & Apex modular cementless femoral stems. Global Orthopaedic Technology, $219,369.
3. Ebert JR, Wood DJ. (2009) Prospective randomised clinical trial assessing the subsidence and rotation of the K2 & Apex modular cementless femoral stems. Hollywood Private Hospital Research Foundation, $11,568.
4. Ebert JR, Ackland TR, Fallon M, Janes G, Zheng MH, Wood DJ. (2010) Improving patient outcome following arthroscopic autologous chondrocyte implantation (APP1003452). National Health & Medical Research Council, $333,989.
5. Ebert JR, Wood DJ, Ackland TR. (2010) Accelerated rehabilitation following arthroscopic matrix-induced autologous chondrocyte implantation. Hollywood Private Hospital Research Foundation, $12,680.
6. Ebert JR. (2010) Traditional & accelerated rehabilitation following matrix-induced autologous chondrocyte implantation: 2-year MRI outcomes, and correlation with clinical outcomes. Genzyme Corporation, $7,000.
7. Ebert JR. (2010) A prospective clinical evaluation of matrix-induced autologous chondrocyte implantation at five years. Genzyme Corporation, $6,000.
8. Ebert JR, Joss B, Smith T, Bongiascia, Wood DJ . (2011) Improving patient outcome following total knee replacement with remedial massage for the management of post-operative oedema. Hollywood Private Hospital Research Foundation, $7,610.
9. Ebert JR. (2011). Non-randomized, pilot comparison of open and arthroscopically performed matrix-induced autologous chondrocyte implantation. Genzyme Corporation, $17,447.
10. Ebert JR. (2011) A prospective, randomized comparison of traditional and accelerated approaches to post-operative rehabilitation following autologous chondrocyte implantation: 5-year clinical and radiological follow up. Genzyme Corporation, 26,697.
11. Wood DJ, Ebert JR. (2012) Prospective randomised clinical trial assessing the subsidence and rotation of the AM & TM cementless femoral stems. Zimmer Orthopaedics, $192,713.
12. Ebert JR, Joss B, Janes G. (2013) Augmented Hip Abductor Reconstruction for Gluteal Tendon Tears. Hollywood Private Hospital Research Foundation, $11,529.
13. Wood DJ, Ebert JR. (2013) A Prospective Consecutive Series Assessing Migration and Rotation of the Absolut Modular Cemented Femoral Stem. Global Orthopaedic Technology, $51,816.
14. Ebert JR, Wood D, Carey-Smith R. (2014) Clinical and radiological outcome 10 years following matrix-induced autologous chondrocyte implantation (MACI): accelerated versus conservative rehabilitation. Hollywood Private Hospital Research Foundation, $9,141.
15. Ebert JR, Carey-Smith R, Janes G. (2014) Limb asymmetry following anterior cruciate ligament (ACL) reconstruction: Implications for the return to sport and risk of re-injury. Hollywood Private Hospital Research Foundation, $9,141.
16. Janes G, Ebert JR. (2015) Augmented Hip Abductor Reconstruction for Gluteal Tendon Tears, Corin Group, $15,690.
17. Annear P, Ebert JR. (2016) Does the Double Bundle Remnant Sparing ACLR graft construct allow a safe earlier return to sport? A prospective randomized controlled study of fast and standard rehabilitation and its affect on this graft construct, Smith and Nephew, $37,200.
18. Wood DJ, Ebert JR. (2017) Total knee arthroplasty with comparison of inset versus onlay patella resurfacing: investigation of anterior knee pain and function, Zimmer Biomet, $79.826.
19. Annear P, Ebert JR. (2018) Comparison of double bundle anterior cruciate ligament reconstruction using either hamstrings or LARS augmentation: 7-8 year follow-up, Corin Group, $91,160.
20. Annear P, Ebert JR. (2018) A prospective study investigating patient outcome following anterior cruciate ligament reconstruction using a hamstrings autograft augmented with FibreTape®, Arthrex Group, $167,728.
21. Munsie C, Ackland T, Ebert J, Joske D (2018). FiGHTING F!T: A randomised controlled trial of a supervised exercise intervention during treatment for cancer in adolescents and young adults, Exercise and Sport Science Australia (ESSA) Clinical Exercise Physiology Research Grant, $16,000.
22. Falconer T, Lawther B, Ebert J, Shales S (2018). Improving post-operative pain control in arthroscopic rotator cuff repairs: a prospective, blinded, randomised control trial comparing interscalene catheters and single shot blocks (RF113), Hollywood Private Hospital Research Foundation, $15,000.
23. Annear P, Ebert J (2018). A prospective Evaluation of Arthroscopic All Inside Meniscal Repair Repair in Paediatric Patients, DePuy Synthes, $44,025.
24. Radic R, Ebert J, Calvert N (2020). Hamstring Tendon Autograft versus Quadriceps Tendon Autograft for Anterior Cruciate Ligament Reconstruction: A Randomised Controlled Trial, ISAKOS, $24,640.
25. Annear P, Ebert J (2020). A prospective, single centre, cohort study investigating patient outcomes following proximal hamstring surgical repair, ConMed, $48,600.
26. D'Alessandro P, Ebert JR (2021). A Randomised Controlled Trial Comparing Study vs. Dual Hamstring Tendon ACL Reconstruction, Smith and Nephew, $106,300.
27. Radic R, Edwards P, Blackah N, Ebert J (2021). Lower limb performance and kinetics during vertical jump tasks following anterior cruciate ligament reconstruction to aid in relation to play decision making, Hollywood Private Hospital Research Foundation, $10,000.
28. Calvert N, Ebert J, Wysocki D, Kuster M (2021). A comparison of kneeling ability after lateral or midline incisions in total knee arthroplasty, Hollywood Private Hospital Research Foundation, $10,000.
29. Ebert JR (2022). A minimum 10-year post-operative clinical and radiological follow-up of patients following Matrix-induced Autologous Implantation (MACI) to the tibiofemoral and patellofemoral joint, Vericel, $67,560.
30. Radic, Ebert JR (2023). A prospective pilot study investigating the postoperative outcome of patients undergoing ACL repair (IIRR-01680), Arthrex, $76,400.

1. The evaluation of surgical outcome, and the development of pre- and post-operative exercise rehabilitation protocols to enhance patient outcome following articular cartilage surgery in the knee.
2. Development and improvement of gluteal tendon repair surgery, and specific pre-operative exercise management and post-operative rehabilitation protocols, for optimal long-term patient clinical outcomes and biomechanics.
3. Post-operative rehabilitation and return to activity/sport following anterior cruciate ligament reconstruction.
4. The investigation of prosthetic total hip and knee replacement design in optimal long-term patient clinical outcomes, prosthetic stability and bone growth.